Enjoy complimentary customisation on priority with our Enterprise License!
The global pharmaceutical equipment market size is estimated to grow by USD 5,454.44 million at a CAGR of 6.67% between 2022 and 2027.
There is a rising demand for generic drugs across the pharmaceutical sector. Generic drugs can be referred to as low-cost drugs which have therapeutic safety and effectiveness characteristics that are similar to branded versions. The main reason for the growing expansion of therapeutic drugs is the rising demand to minimize healthcare costs. Hence, several governments across the world are encouraging the use of generic drugs. Additionally, the patent expiration of branded drugs is also positively impacting the market. For instance, in South Korea, around 51 patents, which cover more than 150 pharmaceutical products, are scheduled to expire in 2023. Hence, such factors are expected to positively impact the market growth during the forecast period.
Technavio has segmented the market into Product Type, Type, and Geography.
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.
To learn more about this report, Request Free Sample
The solid segment is estimated to witness significant growth during the forecast period. The solid segment mainly comprises the manufacturing of OSD forms of drugs. OSD can be defined as pharmaceutical products that are administered orally in different forms such as tablets, capsules, or powders. There is increasing adoption of OSD in the pharmaceutical sector due to its several benefits such as convenience, stability, accurate dosing, and controlled release capabilities.
Get a glance at the market contribution of various segments View a PDF Sample
The solid segment was the largest segment and was valued at USD 6,850.92 million in 2017. Additionally, OSD forms of solid segments are very easy to handle and need minimal preparation time when compared to other dosage forms, such as injections or liquids. Hence, OSD is ideal for self-administration, enabling patients to take their medication at home without requiring external assistance. Furthermore, other benefits of OSD include better stability and longer shelf life. OSD is less susceptible to degradation and can have a high tolerance to different environmental conditions, such as temperature and humidity changes as they are in solid form. Hence, such factors are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.
Packaging equipment is an essential part of the global pharmaceutical equipment market. It mainly comprises machines and systems utilized for the packaging and labeling of pharmaceutical products in order to ensure their safety, integrity, and compliance with regulatory requirements. There are several stringent regulatory rules and guidelines enforced by the government on these pharmaceutical companies that facilitate secure and compliant packaging to ensure the safety of pharmaceutical products. For example, pharmaceutical packaging must comply with pharmacopeia requirements. Factors such as the increase in demand for innovative drug delivery forms and personalized medicine is fuelling the growth of this segment which in turn will drive the market growth during the forecast period.
Granulating equipment is mainly utilized in the pharmaceutical industry for the process of granulation, which includes transforming fine powders into larger, more uniform particles known as granules. The main advantage of this process is that it enhances the flowability, compressibility, and stability of the pharmaceutical formulations. Additionally, this process helps in achieving uniformity in particle size and distribution, resulting in consistent drug dosage and efficacy. Factors such as the increasing development of new drug formulations and the requirement for quality and efficiency are fuelling the growth of this segment which in turn will drive the global pharmaceutical equipment market growth during the forecast period.
For more insights about the market share of various regions View PDF Sample now!
Asia is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Another region offering significant growth opportunities to companies is North America. One of the main countries which is significantly contributing to the growth of the global pharmaceutical equipment market in North America is the US. The presence of several prominent biotechnology companies in the region is significantly fuelling market growth. For example, Pfizer Inc., which is one of the world's largest pharmaceutical companies, is headquartered in the US, and the company is known to provide R and D solutions to different pharmaceutical companies across the globe.
Additionally, there is wide adoption of diverse pharmaceutical equipment across this company for new drug production processes. Furthermore, there is an increase in the number of biopharmaceutical and biosimilar product approvals in North America over the last few years. Also, in the US there are high investments in R&D of gene- and other nucleic acid-based products such as antisense oligonucleotides (ASOs). Moreover, one of the prominent leaders in the global generic drugs market is North America. Several prominent market players such as Elli Lilly, Merck, Pfizer, and Amgen are based in the US. Hence, such factors are expected to drive the global pharmaceutical equipment market growth in the region during the forecast period.
In 2020, during the COVID-19 pandemic, the growth of the global pharmaceutical equipment market witnessed a mixed impact as the rising demand for pharmaceutical products and the urgent need to develop and manufacture vaccines, drugs, and, medical devices have led to an increase in demand for pharmaceutical equipment. On the other hand, it has led to disruptions in global supply chains, resulting in shortages and delays in the production and delivery of pharmaceutical equipment. However, in 2021, the initiation of large-scale vaccination drives lifted the lockdown and travel restrictions, which led to the resumption of the treatment of medical conditions such as chronic diseases and increased the demand for pharmaceutical products. Such factors are expected to drive the market during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
One of the key factors driving the global pharmaceutical equipment market growth is the rising prevalence of diseases and increasing demand for pharmaceuticals. There is an increasing prevalence of chronic diseases due to several risk factors including diabetes, hypertension, the consumption of tobacco, and obesity. Hence, there is an increase in the use of OSD drugs among patients as they seek out effective and convenient treatment options for their chronic conditions.
For example, there is wide adoption of aspirin for preventing heart attacks, strokes, and other cardiovascular conditions in patients with a history of heart disease or who are at high risk of developing it. Furthermore, ibuprofen and acetaminophen are significantly used to reduce pain and inflammation associated with conditions such as arthritis, chronic back pain, and headaches. Hence, this rise in chronic conditions is fuelling the demand for OSD drugs which is expected to drive the global pharmaceutical equipment market growth during the forecast period.
A key factor shaping the global pharmaceutical equipment market growth is the technological advances in pharmaceutical equipment. One of the main factors which is significantly contributing to the growth of the global pharmaceutical equipment market is the advancement in technologies such as the introduction of innovative solutions, enhancing efficiency, improving safety, and enabling new capabilities. Additionally, the emergence of automation and robotics has changed the landscape of pharmaceutical production.
Moreover, the main advantage of this advancement in technology is that it has enhanced efficiency and precision while minimizing manual errors and labor costs. Integration of data analytics and artificial intelligence (AI) in pharmaceutical equipment is another major technological advancement in pharmaceutical production. The main advantage of the implementation of AI is that it can analyze AI algorithms can analyze large volumes of data to identify patterns, predict outcomes, and optimize processes. Hence, such technological advancements are expected to drive market growth during the forecast period.
The high cost of pharmaceutical equipment is one of the key challenges hindering market growth. One of the prime examples of the high costs associated with pharmaceutical equipment is large-scale production machinery. Several manufacturing facilities need equipment such as tablet presses, capsule filling machines, and blister packaging machines for the efficient production of pharmaceutical products
In addition, the price range of this machinery varies from USD 50,000 to USD 80,000, depending on several factors such as capacity, features, and specifications. analytical instruments required for quality control and testing is another expensive machinery segment that contributes to higher costs. Some of the main machinery in pharmaceutical manufacturing include high-performance liquid chromatography (HPLC) systems, mass spectrometers, and particle size analyzers to ensure product quality and compliance. Thus such expensive equipment can negatively impact the market which in turn will hinder the global pharmaceutical equipment market growth during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Pharmaceutical Equipment Market Customer Landscape
The pharmaceutical equipment market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Pharmaceutical Equipment Market Scope |
|
Report Coverage |
Details |
Page number |
172 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.67% |
Market growth 2023-2027 |
USD 5,454.44 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
5.68 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
Asia at 34% |
Key countries |
US, Germany, UK, China, and India |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
ACG, ACIC Pharmaceuticals Inc., Alfa Laval AB, Antares Vision S.p.A, Astro Machine Works Inc., Bausch plus Strobel Maschinenfabrik Ilshofen GmbH plus Co. KG SE, Coesia SpA, Freund Corp., GEA Group AG, Hillenbrand Inc., IDEX Corp., IMA Industria Macchine Automatiche Spa, Koerber AG, Maquinaria Industrial Dara SL, Marchesini Group Spa, Merck KGaA, Romaco Holding GmbH, Silverson Machines Inc., Syntegon Technology GmbH, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.